Skip to content
healthcare.dev
Get a free key

Susvimo

NDC 50242-078, Ranibizumab, injection, solution, from Genentech, Inc..

Product NDC
50242-078
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVITREAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761197
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-078 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANIBIZUMAB100 mg/mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]

Package NDCNDC-11Package
50242-078-12502420078121 VIAL in 1 CARTON (50242-078-12) / 1 mL in 1 VIAL
50242-078-55502420078551 VIAL in 1 CARTON (50242-078-55) / 1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9c6d9e2a-9a77-4d11-b692-de87cfde3444

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-078

Use it

Look up 50242-078 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-078 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-078. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.